BSE Live
Oct 01, 11:24Prev. Close
190.90
Open Price
190.85
Bid Price (Qty.)
195.50 (97)
Offer Price (Qty.)
195.70 (579)
NSE Live
Oct 01, 11:24Prev. Close
191.16
Open Price
191.07
Bid Price (Qty.)
195.55 (50)
Offer Price (Qty.)
195.59 (5760)
Cash Flow of Piramal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 13 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 911.14 | 507.62 | 130.65 | 436.70 | 668.55 | |
Net CashFlow From Operating Activities | 548.77 | 358.29 | 71.52 | 255.20 | 34.72 | |
Net Cash Used In Investing Activities | -549.98 | -635.52 | -435.05 | -1,223.02 | -4,382.89 | |
Net Cash Used From Financing Activities | -61.74 | 451.38 | 290.12 | 905.74 | 4,494.16 | |
Foreign Exchange Gains / Losses | -1.98 | 0.37 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | -64.93 | 174.52 | -73.41 | -62.08 | 145.99 | |
Cash And Cash Equivalents Begin of Year | 228.80 | 54.28 | 127.69 | 146.73 | 0.74 | |
Cash And Cash Equivalents End Of Year | 163.87 | 228.80 | 54.28 | 84.65 | 146.73 |
31.07.2025
30.07.2025
29.07.2025
Piramal Pharma Consolidated June 2025 Net Sales at Rs 1,933.71 crore, down 0.89% Y-o-Y
14.07.2025
29.07.2025
Piramal Pharma Consolidated June 2025 Net Sales at Rs 1,933.71 crore, down 0.89% Y-o-Y
19.05.2025
Piramal Pharma Standalone March 2025 Net Sales at Rs 1,689.80 crore, up 10.78% Y-o-Y
14.05.2025
Piramal Pharma Standalone March 2025 Net Sales at Rs 1,689.80 crore, up 10.78% Y-o-Y
14.05.2025
Piramal Pharma Consolidated March 2025 Net Sales at Rs 2,754.07 crore, up 7.9% Y-o-Y